1 Result(s)

Article

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure

Treatment options for patients with lower risk non-del(5q) myelodysplastic syndromes (MDS) who fail erythroid stimulating agents are restricted to one of the hypomethylating drugs with an expected response rat...

Fahd Quddus, Jessica Clima, Helen Seedham… in Journal of Hematology & Oncology (2010)